pioglitazone has been researched along with Kidney Calculi in 8 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Kidney Calculi: Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone treatment improved features of the metabolic syndrome." | 2.90 | Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone. ( Adams-Huet, B; Maalouf, NM; Moe, OW; Poindexter, JR; Sakhaee, K, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maalouf, NM | 1 |
| Poindexter, JR | 1 |
| Adams-Huet, B | 1 |
| Moe, OW | 1 |
| Sakhaee, K | 2 |
| Asplin, JR | 1 |
| Goldfarb, DS | 1 |
| Assimos, DG | 2 |
| Niu, SW | 1 |
| He, JS | 1 |
| You-Hsien Lin, H | 1 |
| Maalouf, N | 1 |
| Torricelli, FC | 1 |
| De, S | 1 |
| Gebreselassie, S | 1 |
| Li, I | 1 |
| Sarkissian, C | 1 |
| Monga, M | 1 |
| Taguchi, K | 1 |
| Okada, A | 1 |
| Yasui, T | 1 |
| Kobayashi, T | 1 |
| Ando, R | 1 |
| Tozawa, K | 1 |
| Kohri, K | 1 |
1 trial available for pioglitazone and Kidney Calculi
| Article | Year |
|---|---|
Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone.
Topics: Adult; Aged; Ammonium Compounds; Female; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Male; M | 2019 |
7 other studies available for pioglitazone and Kidney Calculi
| Article | Year |
|---|---|
Effect of thiazolidinedione therapy on the risk of uric acid stones.
Topics: Acids; Humans; Kidney Calculi; Pioglitazone; Thiazolidinediones; Uric Acid | 2019 |
Re: Increased Production and Reduced Urinary Buffering of Acid in Uric Acid Stone Formers is Ameliorated by Pioglitazone.
Topics: Humans; Kidney Calculi; Pioglitazone; Uric Acid; Urinary Calculi | 2019 |
Pioglitazone and nephrolithiasis.
Topics: Humans; Kidney Calculi; Nephrolithiasis; Pioglitazone; Uric Acid | 2019 |
The authors reply.
Topics: Humans; Kidney Calculi; Pioglitazone; Uric Acid | 2019 |
Re: Increased Production and Reduced Urinary Buffering of Acid in Uric Acid Stone Formers is Ameliorated by Pioglitazone.
Topics: Humans; Kidney Calculi; Pioglitazone; Uric Acid; Urinary Calculi | 2019 |
Type-2 diabetes and kidney stones: impact of diabetes medications and glycemic control.
Topics: Administration, Oral; Aged; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; | 2014 |
Pioglitazone, a peroxisome proliferator activated receptor γ agonist, decreases renal crystal deposition, oxidative stress and inflammation in hyperoxaluric rats.
Topics: Animals; Crystallization; Hyperoxaluria; Inflammation; Kidney; Kidney Calculi; Male; Oxidative Stres | 2012 |